Company intelligence / Profile preview

Cascador Health

Ownership: Private
Development stage: Other

Overview

Cascador Health enables secure, compliant access to structured and anonymized real-world medical data across Europe. Its flagship program CHRINOSOR generates robust real-world evidence in chronic rhinosinusitis with nasal polyps. The company’s federated architecture ensures patient privacy while supporting pharmaceutical sponsors and clinical centers with actionable insights.

Therapeutic areas: Immunology
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Pharmaceutical sponsors involved in registry programs like CHRINOSOR.Strategic partnerships with European healthcare providers and key opinion leaders.

Beyond the preview

Go deeper on Cascador Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cascador Health.

Explore the full profile